Gland Pharma’s stock surged on the BSE, following the successful conclusion of a Pre-Approval Inspection (PAI) by the United States Food and Drug Administration (USFDA) at its Visakhapatnam facility. The stock is currently trading at ₹1,616.15, up by ₹20.65 or 1.29%, compared to its previous closing price of ₹1,595.50.

Stock Performance Overview
- Opening Price: ₹1,604.85
- Day’s High: ₹1,649.95
- Day’s Low: ₹1,587.10
- 52-Week High: ₹2,220.95 (August 6, 2024)
- 52-Week Low: ₹1,412.00 (February 12, 2025)
- One-Week High/Low: ₹1,649.95 / ₹1,473.45
- Market Capitalization: ₹26,989.63 crore
The promoters hold a 51.83% stake in the company, while institutions and non-institutions hold 39.84% and 8.33%, respectively.
USFDA Inspection Details
The USFDA conducted the Pre-Approval Inspection (PAI) for Sterile Active Pharmaceutical Ingredients (APIs) at Gland Pharma’s JNPC, Visakhapatnam facility between February 19 and February 25, 2025.
The inspection concluded with three Form 483 observations, which the company stated were procedural in nature. Gland Pharma confirmed that the observations are neither repeat violations nor related to data integrity. The company is set to submit its corrective and preventive actions to the USFDA within the stipulated timeframe.
Company Outlook
Gland Pharma is a leading developer, manufacturer, and marketer of complex injectables, primarily operating under a business-to-business (B2B) model across multiple global markets. The positive outcome of the USFDA inspection reinforces the company’s regulatory compliance and operational stability, which could boost investor confidence moving forward.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.




